Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 16 Carcinoma, Intraductal, Noninfiltrating 2 Li-Fraumeni Syndrome 1 Inflammation 1 Hamartoma Syndrome, Multiple 1 Cystic Fibrosis 1 Breast Carcinoma In Situ 1 Breast Cancer Female 1

Interventions

Surgical Procedures, Operative 2 Blood Specimen Collection 2 ziprasidone 1 semaglutide 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Zolpidem 1 Weights and Measures 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topiramate 1 Tobramycin 1 Tirzepatide 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Radiotherapy 1 Qsymia 1 Piperacillin, Tazobactam Drug Combination 1 Pioglitazone 1 Phentermine 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Neoadjuvant Therapy 1 Naltrexone 1 Nafcillin 1 Molindone 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Inflammation × Mastectomy × Clear all

NCT06447532 2025-03-12

INFLAMMATE

Federal University of São Paulo

Enrolling by invitation

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡